Abstract:Human xeroderma pigmentosum complementation group A (XPA) is a scaffold protein that plays significant roles in DNA-damage verification and in recruiting downstream endonucleases to facilitate the repair of DNA lesions in nucleotide-excision repair. XPA98-219 (residues 98-219) has been identified as a DNA-binding domain and has been extensively studied in the last two decades. However, the most recent studies have redefined the DNA-binding domain as XPA98-239 (residues 98-239); it exerts a remarkably higher DNA-binding affinity than XPA98-219 and has a binding affinity that is quite similar to that of the full-length protein. Here, the production, crystallization and structure solution of human XPA98-239 are described. Crystals were obtained using a precipitant composed of 1.8 M ammonium citrate tribasic pH 7.0. Native X-ray diffraction data and zinc single-wavelength anomalous diffraction (SAD) data were collected to 1.93 and 2.06 Å resolution, respectively. The crystals belonged to space group P3, with unit-cell parameters a = 67.1, b = 67.1, c = 35.6 Å, γ = 120.0°. Crystal-content analysis showed the presence of one molecule in the asymmetric unit, corresponding to a Matthews coefficient of 2.65 Å3 Da-1 and a solvent content of 53.6%. The initial phases were solved and the structure model was automatically built by zinc SAD using the AutoSol program. The initial structure model covered 119 of 142 residues in the asymmetric unit, with an Rwork of 22.15% and an Rfree of 25.82%. Compared with a previously obtained truncated solution NMR structure of XPA (residues 98-210), a 19-residue C-terminal extension (residues 211-229, corresponding to 10 of the 20 extra C-terminal residues in the redefined domain for enhanced DNA binding) was contained in this initial model. Refinement of the atomic coordinates of XPA is ongoing.

Cloning and Expression of Xeroderma Pigmentosum Complementation Group A Cdna and the Identification of Its Recombinant Protein

[Cloning of Transmembrane Domain Sequence of EGFR Gene]

Identification and characterization of xpac protein, the gene product of the human XPAC (xeroderma pigmentosum group A complementing) gene

Molecular Cloning and Protein Expression of Ec1-2 and Ec3-4 Epitopes of Pemphigus Vulgaris Antigen

Cloning of the XPD gene and its function in malignant melanoma cells

[Construction, Expression and Purification of a Mammalian Secretory Recombinant Fusion Protein Rpc].

Generation of XPA p.Arg228T mutant LUMCi004-A cell line for modeling Xeroderma pigmentosum group A

The Redefined DNA-binding Domain of Human Xeroderma Pigmentosum Complementation Group A: Production, Crystallization and Structure Solution.

Identification of Four Novel XPC Mutations in Two Xeroderma Pigmentosum Complementation Group C Patients and Functional Study of XPC Q320X Mutant.

Cloning and Expression of Intracellular Part of Receptor Protein Tyrosine Phosphatase RPTPα and Preparation of Its Polyclonal Antibodies

Cloning, Expression and Polyclonal Antibody Preparation of UGRP1 and Its Subcellular Localization

The Expression and Characterization of Gene Cloning of Human LYVE-1 in Methylotrophic Yeast Pichia Pastoris System

491 Identification of Four Novel XPC Mutations in Two Xeroderma Pigmentosum Complementation Group C Patients and Functional Study of XPC Q320X Mutant

Cloning and identification of full-length DCC cDNA and construction of its eukaryotic expression vector

[PCR Amplification, Cloning and Expression of the Gene Coding for CD4 V1-V2 Domains].

Full-length Cdna Cloning, Sequence Analysis and Protein Expression of Retinoic-Acid Induced Gene C

Construction of Pgex4t-1-cox7a2 and Expression, Purification and Identification of the Recombinant Protein

[Expression, Purification and Characterization of Recombinant Human Cyclophilin A].

[Cloning and Expression of Extracellular Domain of Prostate Specific Membrane Antigen in Escherichia Coli and Preparation of Polyclonal Antibody].

Cloning and Expression of a Fused Gene Encoding TNFRI Death Domain and Chloramphenicol Acetyltransferase.

[Prokaryotic Expression, Purification and Identification of Recombinant Xenopus Laevis and Mouse Vascular Endothelial Growth Factors].